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Abstract
Introduction Longitudinal studies on the age-related bone
loss in men concerns the decrease in areal bone mineral
density (aBMD), which can be qualified as “apparent bone
loss” because it does not reflect the change in bone mineral
content (BMC). Loss of BMC can be referred to as “net
bone loss” because it does not take into account the
morphological basis of the bone loss (decreased periosteal
apposition; endosteal bone loss, i.e. bone loss on the
trabecular, endocortical and intracortical surfaces). The
aim of this study was to assess age-related apparent net
and endosteal bone loss as well as their morphological basis
and age-related changes during a prospective follow-up in a
large cohort of elderly men.
Methods This analysis was performed in 725 men aged 51–
85 at baseline who were followed up for 90 months.
Results Bone densitometry was carried out at the lumbar
spine, hip and whole body by using the HOLOGIC
QDR1500 device and at the distal forearm by using the
Osteometer DTX100 device. Sixty-five men who aban-
doned the study after the first examination were older and
had lower aBMC at most sites of measurement. Apparent
bone loss was significant at the hip, distal forearm and
whole body. Net bone loss was also significant at these
sites, except for the femoral neck. Periosteal expansion was
significant at all sites of measurement. Apparent and net
bone loss accelerated with age, whereas the rate of
periosteal expansion remained stable. At the distal radius
and ulna, endosteal bone loss accelerated with age, whereas
the rate of periosteal apposition remained stable.
Conclusion In a large cohort of elderly men, age-related
apparent bone loss (aBMD) at the hip, distal forearm and
whole body was determined by the net bone loss (BMC),
except for the femoral neck. Apparent and net bone loss
accelerated with age, whereas the periosteal expansion rate
(bone widening) remained constant. At the distal forearm,
age-related acceleration of the apparent bone loss was
determined by the higher endosteal bone loss, whereas the





Osteoporosis in elderly men is a major problem of public
health. Fracture incidence increases exponentially with age,
thus, total number of fragility fractures in men increases
rapidly, mainly due to the increasing life expectancy [1].
Currently, 25–30% of fragility fractures occur in men [1, 2].
Moreover, postfracture morbidity and mortality are higher
in men than in women [3, 4].
Bone loss is defined usually as the rate of decrease in
areal bone mineral density (aBMD) measured by dual
X-ray absorptiometry (DXA) [5–7]. However, aBMD of
a given region of interest (ROI) is determined by its bone
mineral content (BMC) and by its projected area. For
tubular bones, ROI length is kept constant, and the
projected area depends on bone width. Bone width
increases with ageing due to the periosteal apposition
[8, 9]. Thus, if the amount of bone deposited on the
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surfaces (i.e. trabecular, endocortical and intracortical)
are equal, BMC remains constant, but aBMD decreases
because bone width and its projected area have increased.
Therefore, it is more appropriate to refer the decrease in
aBMD assessed longitudinally as “apparent bone loss”.
Changes in BMC of a given ROI are determined not
only by the quantity of bone resorbed on the endosteal
surfaces but also by the quantity of bone deposited on the
periosteal surface. Thus, change in BMC does not reflect
the quantity of bone really lost on the endosteal surfaces
and, therefore, the decrease in BMC is better qualified as
“net bone loss”. Estimation of bone gain due to periosteal
apposition would allow assessment of the quantity of bone
really lost on the endosteal surfaces. This quantity of bone
could be referred as to “endosteal bone loss”.
In elderly men, apparent bone loss accelerates with age
[5–7]. However, the morphological basis underlying this
acceleration has not been studied, and it is unclear whether
it is related to faster outward displacement of a constant
amount of bone, to higher endosteal bone loss and/or to a
lower periosteal apposition. Moreover, only a few studies
have compared the rate of apparent bone loss at different
sites of measurement in elderly men [10–12], although it
appears that the morphological basis underlying apprent
bone loss may vary according to ROI [13].
Therefore, the aim of this study was to assess age-related
apparent net and endosteal bone loss as well as their
morphological basis and the age-related changes during a
long-term prospective follow-up in a large cohort of elderly
men (the MINOS study).
Subjects and methods
Cohort
The MINOS study is a prospective study of osteoporosis and
its determinants in men, which was initiated in 1995 [14]. It
is the result of a collaboration between the National Institute
of Health and Medical Research (INSERM) and Société de
Secours Minière de Bourgogne (SSBM) in Montceau les
Mines, a town located 130 km northwest of Lyon in the
Department (District) of Saône et Loire. The town has a
population of 21,000 inhabitants, including 7,150 men >
19 years if age. SSMB is one of the largest health insurance
companies in this town. The study was performed in accord
with the Helsinki Declaration of 1975 as revised in 1983.
The MINOS cohort consists of 1,040 men aged 19–85
recruited between 1995 and 1998. All men responded to an
epidemiological questionnaire covering demographic and
behavioural information as well as detailed medical history.
Men aged 19–50 were examined once, whereas 790 men
aged 50–85 were followed up prospectively for 90 months.
Every 18 months, they were invited to attend the follow-up
examination composed of an epidemiological questionnaire
and DXA measurement. Radiograph of the spine were
performed at baseline, 36 and 90 months.
Measurements
aBMD and BMC were measured at the lumbar spine (L2–
L4), hip and whole body using pencil-beam DXA (QDR
1500, Hologic Inc., Waltham, MA, USA) and at the distal
nondominant forearm using single energy X-ray absorpti-
ometry (Osteometer, DTX-100, Denmark). The OsteoDyne
Hip Positioner System (HPS) was used to minimise hip
positioning error. ROI of the femoral neck was positioned
perpendicularly to the axis of the femoral neck to cover its
narrowest part. When necessary, the femoral neck edges
were adjusted manually. The QDR 1500 device was
calibrated daily using a lumbar spine phantom, yielding a
CV for aBMD of 0.33 %. Twice a month, the Hologic hip
phantom was measured, yielding a long-term CVof 0.94 %
for femoral neck aBMD and 1.05 % for the femoral neck
projected area. Also twice a month, a human lumbar spine
embedded in methyl methacrylate was measured. Its long-
term CV was 1.07 % for BMC of L2–L4, 1.07 % for the
projected area of L2–L4, and 0.62 % for aBMD of L2–L4.
At the distal forearm, the distal site includes 20 mm of
radius situated proximally to the site where the spacing
between the medial edge of the radius and the lateral edge
of the ulna is 8 mm. Scans with evident error of positioning
were excluded. The densitometer was calibrated daily using
a calibration standard for DTX 100; its long-term CV was
0.47 % for aBMD and 0.15 % for the projected area.
Dimensions of the vertebral body of the third lumbar
vertebra(L3)weremeasuredontheanteroposteriorandlateral
radiographs of the lumbar spine performed at baseline and at
90 months. The cross-sectional area of L3 was calculated
based on the anteroposterior and frontal diameters measured
inthenarrowestsiteofthevertebralbody.Osteoarthritisofthe
lumbar spine was assessed, as described previously [14].
The external diameter of bone was calculated as the
projected area of ROI divided by its length. The rate of age-
related periosteal expansion was calculated as the average
annual increase in the external diameter (femoral neck,
distal radius and distal ulna), projected area (total hip) or
cross-sectional area (L3). Age-related periosteal apposition
(ΔBMCPA) was estimated as the mass of bone deposited on
the outer surface of bone since the first measurement
(Fig. 1). The volume of the ellipsoid cylinder was
calculated assuming that the short axis was 0.75 of the long
axis (external diameter). Then, the mass of the deposited
bone was calculated as the product of the cylinder volume
and the volumetric density of bone mineral (1.15 g/cm
3)
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determined by baseline BMC, bone mass deposited on the
outer surface (ΔBMCPA) and endosteal bone loss
(ΔBMCEBL). Thus, ΔBMCEBL can be calculated using
BMC at baseline and during the follow-up and the calculated
value of ΔBMCPA. The concept of endosteal bone loss does
not make any assumption as to its underlying morphological
basis (cortical thinning, increased cortical porosity, trabecular
bone loss) nor on the proportion of cortical to trabecular
bone. It only reflects the loss of bone mineral “inside” bone,
which is represented in Fig. 1 by the change of the colour
from black to grey.
Statistical methods
All calculations were performed by using SAS version 8.2
software (SAS Institute Inc., Cary, NC, USA). Correlation
between continuous variables was assessed by Pearson’s
simple correlation coefficient. Individual slopes were
calculated by using simple linear regression. Comparisons
of the individual slopes between age groups were per-
formed by analysis of variance (ANOVA) and adjusted for
multiple comparisons by Dunnett-Hsu test. Participants
attended two to six exams; those who had few measure-
ments, e.g. two, had them over different periods of follow-
up (18–90 months). Individual slopes were calculated by
using two to six points distributed over 18–90 months,
which could influence accuracy of the calculation. We
adjusted for the duration of follow-up or the number of
measurements to check whether duration of follow-up and
number of measurements influenced the results. Each of
them entered significant in the majority of models, although
they influenced the results only to a limited degree. We
present data adjusted for the duration of follow-up because
this variable attained higher level of significance in the
models and contributed more to the final model.
Results
Characteristics of the investigated cohort
Sixty-five men who abandoned the study after the first
examination were, at baseline, older and had lower physical
Fig. 1 Calculation of bone mass deposited by periosteal apposition
(ΔBMCPA) and of endosteal bone loss (ΔBMCEBL) between baseline
(t0) and follow-up (t1). Long semi-axes of the ellipse at baseline (R0)
and during the followup (R1) are equal to half the external diameter of
the region of interest (ROI). Bone mass deposited by periosteal
apposition (ΔBMCPA) is the product of the ellipsoid volume and the
vBMD of cortical bone (d=1.15 g/cm
3). Coefficient 0.75 reflects bone
flattening in the anteroposterior projection in comparison with its
diameter in the frontal projection. Endosteal bone loss (ΔBMCEBL)i s
presented graphically as the brighter colour of the entire cross-
sectional area of bone (black at baseline and light grey at follow-up) in
order to indicate that the “endosteal bone loss” makes no distinction as
to the morphological basis (cortical thninning, increase in cortical
porosity, trabecular bone loss)
Osteoporos Int (2007) 18:495–503 497activity but higher prevalence of diabetes mellitus, rheu-
matoid arthritis and parkinsonism than the 725 men who
participated in the follow-up (Table 1). They had lower
aBMD and BMC at all sites of measurement except for the
lumbar spine. The difference between the groups became
weaker after the adjustment for age; however, it remained
significant for certain sites.
Characteristics of bone loss
BMC and aBMD of the lumbar spine increased significant-
ly (Table 2) faster in men with severe arthritis (5.95±16.15
vs 1.74±10.96 mg/cm
2/year; p<0.0001). At the femoral
neck, aBMD decreased, whereas BMC increased. For other
sites of measurement (hip, whole body, distal forearm),
both aBMD and BMC decreased. The fractional apparent
and net bone loss (percentage of initial value) were fastest
at the distal forearm and slowest at the whole body. All the
above absolute and fractional changes in aBMD and BMC
were significantly different from 0 for all ROIs.
External diameter of the femoral neck, distal radius and
distal ulna as well as the cross-sectional area of L3 and the
projected area of total hip increased significantly during the
follow-up. Fractional increase in bone size varied from
0.17% to 0.36% per year across the sites.
Characteristics of the rate of bone loss according to age
at baseline
At the hip and distal forearm, rate of apparent bone loss
(change in aBMD) was negatively correlated with age,
indicating and age-related acceleration of apparent bone
loss (Table 2). After the age of 70, the apparent bone loss
was two (for distal forearm) to 23 (for trochanter) times
faster than in men aged younger than 60 at baseline
(Fig. 2). A similar trend was found when apparent bone
loss was expressed as the percentage of the baseline value
of aBMD.
Net bone loss (change in BMC) also accelerated with
age at the total hip, whole body and bones of distal forearm.
In men aged older than 70, net bone loss was two to four
Table 1 Comparison of 725 men participating in the prospective study and 65 men lost to follow-up after recruitment
Parameter Follow-up (n=725) No follow-up (n=65) p value* p value**
Age (years) 65±7 70±8 < 0.0001
Body weight (kg) 80±13 79±15 0.29
Body height (cm) 169±6 168±7 0.21
BMI (kg/m
2) 27.98±3.64 27.75±4.51 0.63
Fat mass (kg) 22.02±7.48 23.23±9.11 0.28
Lean mass (kg) 54.54±6.66 52.16±7.56 < 0.01 NS
Tobacco smoking (%) 11.8 11.6 0.98
Physical activity (h/week) 21.8±12.7 17.2±11.3 < 0.005 NS
Prevalent fractures (%) 13.8 19.7 0.18
Diabetes (%) 6.5 15.7 < 0.005
Rhumatoid arthritis (%) 1.4 5.7 < 0.01
Parkinsonism (%) 1.5 5.7 < 0.02
Lumbar spine BMD (g/cm
2) 1.031±0.184 1.052±0.213 0.21
Femoral neck BMD (g/cm
2) 0.845±0.121 0.803±0.127 < 0.01 NS
Femoral neck BMC (g) 5.111±0.849 4.883±0.934 < 0.04 NS
Femoral neck width (cm) 4.082±0.316 4.123±0.356 0.31
Trochanter BMD (g/cm
2) 0.740±0.109 0.691±0.121 < 0.001 < 0.03
Total hip BMD (g/cm
2) 0.966±0.127 0.910±0.157 < 0.001 NS
Whole-body BMC (g) 2706.6±410.4 2550.3±472.7 < 0.005 NS
Whole-body BMD (g/cm
2) 1.210±0.108 1.167±0.121 < 0.003 < 0.05
Distal forearm BMD 0.524±0.065 0.483±0.070 < 0.0001 < 0.01
Ultradistal radius BMD 0.430±0.064 0.399±0.072 < 0.001 < 0.05
Radius BMD (g/cm
2) 0.556±0.068 0.513±0.075 < 0.0001 < 0.01
Radius BMC (g) 2.743±0.403 2.527±0.422 < 0.0001 < 0.01
Radius width (cm) 2.471±0.207 2.468±0.216 0.94
Ulna BMD 0.476±0.066 0.438±0.070 < 0.0001 < 0.01
Ulna BMC (g) 1.502±0.244 1.401±0.246 < 0.0001 < 0.01
Ulna width (cm) 1.659±0.136 1.684±0.152 0.16
BMD bone mineral density, BMC bone mineral content, NS not significant
p* difference between the groups
p** age-adjusted difference between the groups
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at baseline, both for the absolute values of net bone loss and
for data expressed as percentage of baseline BMC (Fig. 3).
In 183 men aged 50–60, rates of apparent and net bone
loss were significantly different from 0 for all ROIs, except
the trochanter. In 387 men aged 61–70 and in 155 men aged
older than 70 at baseline, rates of apparent and net bone
loss were significantly different from 0 for all ROIs. The
rate of periosteal expansion (expressed as the change in the
projected area of bone) was significantly different from 0
for all ROIs and for all three age groups. However, it did
not vary across age groups for any site of measurement.
Similarly, at distal forearm bones, periosteal apposition
estimated as bone mass deposited annually did not change
across the age groups (Fig. 4). By contrast, estimated
Table 2 Average rate of apparent bone loss [change in areal bone mineral density (aBMD)], net bone loss [change in bone mineral content
(BMC)] and of periosteal expansion (increase in bone width or area) as well as the simple correlation coefficients of these variables with age in
725 men aged 50–85 at baseline followed up prospectively for 90 months (the prospective MINOS study)
Site of measurement Yearly change Correlation with age
Bone mineral density (mg/cm
2/year) (%/year) rp
Lumbar spine 4.205±14.21 0.495±2.910 −0.069 0.07
Femoral neck −2.463±8.305 −0.282±1.019 −0.154 < 0.0001
Trochanter −1.963±8.031 −0.276±1.123 −0.196 < 0.0001
Total hip −4.714±8.451 −0.496±0.930 −0.213 < 0.0001
Whole body −2.081±8.712 −0.177±0.723 −0.045 0.22
Distal forearm −2.937±4.178 −0.580±0.870 −0.202 < 0.0001
Distal radius −2.986±5.340 −0.561±1.041 −0.180 < 0.0001
Distal ulna −3.353±5.131 −0.730±1.206 −0.119 < 0.002
Ultradistal radius −1.823±5.334 −0.426±1.285 −0.128 < 0.001
Bone mineral content (mg/year) (%/year)
L3 118.17±552.90 0.658±2.954 −0.041 0.27
Femoral neck 12.67±50.38 0.263±1.010 −0.051 0.18
Total hip −226.1±0.687 −0.504±1.551 −0.120 < 0.002
Whole body −7565.9±22500.9 −0.294±0.877 −0.192 < 0.0001
Distal radius −11.26±25.90 −0.426±0.978 −0.179 < 0.0001
Distal ulna −8.64±16.82 −0.559±1.164 −0.123 < 0.001
Bone size
L3 cross-section (mm
2/year) 35.64±225.40 0.167±1.184 −0.056 0.10
Femoral neck (μm/year) 133.1±217.2 0.321±0.503 0.070 0.06
Total hip (mm
2/year) 4.82±42.23 0.112±0.915 0.007 0.85
Distal radius (μm/year) 60.48±362.66 0.257±1.497 0.034 0.36
Distal ulna (μm/year) 58.27±156.61 0.355±0.937 0.013 0.73
Table 2 Average rate of apparent bone loss [change in areal bone
mineral density (aBMD)], net bone loss [change in bone mineral
content (BMC)] and of periosteal expansion (increase in bone width or
area) as well as the simple correlation coefficients of these variables
with age in 725 men aged 50–85 at baseline followed up prospectively
for 90 months (the prospective MINOS study)
Fig. 2 Comparison of the
absolute values of apparent bone
loss [change in areal bone min-
eral density (aBMD)] according
to age group (black bars
50–60 years, pointed bars 61–
70 years, white bars > 70 years
at baseline). The slopes are
significantly different from 0
(p<0.005–0.0001) for all
regions of interest (ROIs) and
for all age groups, except for the
trochanter in the youngest group
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70 compared with men aged younger than 60 at baseline.
Discussion
In men, aBMD increased at the spine and decreased at the
hip, distal forearm and whole body. At these sites, apparent
bone loss (change in aBMD) was associated with net bone
loss (change in BMC) except for the femoral neck.
Apparent and net bone loss accelerated with age, whereas
periosteal expansion rate remained stable. At the distal
radius and ulna, endosteal bone loss accelerated with age,
whereas the rate of periosteal expansion remained stable.
Apparent bone loss at the hip and distal forearm was
associated with a parallel net bone loss. At these ROIs,
endosteal bone loss exceeded the periosteal apposition, and
apparent bone loss was determined by outward displace-
Fig. 4 Upper panel: compari-
son of absolute values of annual
rates of increase in external
diameter at the distal radius and
ulna according to age group.
Lower panel: comparison of
absolute values of rates of de-
position of bone mass by peri-
osteal apposition (positive
hatched bars) and rate of end-
osteal bone loss (negative
pointed bars) at the distal radius
and ulna according to age group.
The slopes are significantly dif-
ferent from 0 (<0.005–0.0001)
for periosteal apposition and for
endosteal bone loss for both
bones and for all age groups.
Please note, in the lower panel,
scales are different for radius
and ulna
Fig. 3 Comparison of the ab-
solute values of net bone loss
[(change in bone mineral con-
tent (BMC)] according to age
group (black bars 50–60 years,
pointed bars 61–70 years, white
bars >70 years old). The slopes
are different from 0 (p<0.005–
0.0001) for all regions of inter-
est (ROIs) and for all age groups
500 Osteoporos Int (2007) 18:495–503ment of lower quantity of bone mineral. Longitudinally
assessed age-related apparent bone loss at the hip and distal
forearm has been described in several cohorts of Caucasian
men [5–7, 10, 16], but their morphological basis has not
been investigated. In elderly men, apparent bone loss was
associated with net bone loss at the intertrochanter ROI but
with a gain in BMC at the total hip and femoral neck
(narrow neck ROI) [13]. We found the same trend for the
femoral neck but not for the total hip. This discrepancy is
surprising because our cohort is younger. As the net bone
loss accelerates with age, faster net bone loss (and not bone
gain) could be expected in the older British cohort.
We confirm longitudinal and cross-sectional data on the
gain in aBMD of lumbar spine in elderly men [7, 12, 14,
16–18]. Increase in the cross-sectional area of L3 at the
midheight of the vertebral body is determined mainly by
the periosteal expansion. This part is less involved in
arthritis. Measurements performed on the X-rays allow for
exclusion of the pathological calcifications. We do not
speculate on the morphological basis underlying the
increase in spine aBMD. Vertebral BMC and aBMD in
the posteroanterior projection are determined by changes in
the vertebral body and the posterior arch. Posterior arch and
its processes are built mainly of cortical bone. As their
periosteal surface is relatively high, its age-related gain of
BMC due to periosteal apposition may be considerable. At
the vertebral body, changes in BMC are determined by loss
of trabecular bone inside and by the increase in BMC due
to the periosteal apposition and the aggravation of arthritis.
At the hip and distal forearm, both aBMD and BMC
decreased, in agreement with previous studies [6, 16, 17].
Both apparent and net bone loss accelerated with ageing; by
contrast, periosteal apposition remained constant. Thus,
age-related acceleration of the apparent and net bone loss is
determined by the acceleration of bone loss on endosteal
surfaces. Apparent and net bone loss were significant in all
age groups.
In women, menopause results in the acceleration of
endocortical resorption and deceleration of periosteal
apposition [19]. Thus, after menopause, periosteal apposi-
tion continues, as reported previously by Ahlborg et al.
[20]. However, it does not increase sufficiently to offset
endocortical bone loss. On the contrary, it decreases, which
may contribute to the deterioration of bone strength and
increased fracture risk. We postulated that postmenopausal
osteoporosis is a disease of failed adaptation of bone [19].
However, in men also, age-related increase in endosteal
bone loss is not accompanied by an increase in periosteal
apposition that would offset the possible loss of strength.
Periosteal apposition does not adapt to the endosteal bone
loss and remains stable. This imbalance may result in a
decrease of bone strength. Thus, in men also, osteoporosis
seems to be a disease of failed adaptation.
Our data are consistent with the cross-sectional data
obtained in elderly men by using the high-resolution pe-
ripheral quantitative computerised tomography (hr-pQCT)
showing the increase in bone size at the axial and peripheral
skeleton, as well as endosteal bone loss characterised by
decrease in the trabecular volumetric BMD (vBMD)
determined mainly by the decrease in the trabecular
number, increase in total marrow area and cortical thinning,
indicating endocortical resorption, and decrease in cortical
vBMD [21, 22]. The decrease in cortical vBMD is
determined mainly by the increase in the midcortical and
subendocortical porosity, whereas subperiosteal porosity
and real volumetric density of the mineral of cortical bone
remain relatively stable during ageing [15, 23].
Our data help in understanding the difference in the
age-related increase in fracture incidence. Young men
have bigger bones than women, even after adjustment
for age, weight and height [24, 25]. Then, aBMD and
BMC decrease. Age-related acceleration of apparent and
net bone loss is consistent with the exponential increase
in fracture incidence. However, in contrast to women,
periosteal apposition rate remains stable in men and may
partly offset the endosteal bone loss and associated loss
of bone strength. In elderly men, bones are larger than in
women (because they were larger in youth and age-
related periosteal apposition was greater), net bone loss is
less (because periosteal apposition continues to deposit
bone on the outer surface) and loss of bone strength starts
later (because continuing periosteal expansion compen-
sates partly for the loss of bone strength due to endosteal
bone loss). These data are consistent with epidemiolog-
ical observations that in men, fracture incidence
increases later and, for a given age, is lower than in
women [1, 26, 27].
Our study has limitations. Montceau les Mines is a small
town, and its inhabitants may not be representative of the
French population. The response rate for the invitation was
23%. Men who abandoned the study after the first
examination were older and sicker, although they represent
only 8% of the initial cohort. Men who were followed up
may have been healthier than the general population,
especially in the oldest group. However, this difference
would have underestimated the age-related bone loss and its
age-related acceleration. A number of men had lower
number of DXA scans because they did not attend
examinations regularly or abandoned the study before the
end of the follow-up. A low number of DXA values and
shorter follow-up could influence the accuracy of estima-
tion of slopes. However, adjustment for the follow-up
duration or the number of scans did not influence the
results.
DXA presents limitations in the evaluation of bone
width. In very old men, subperiosteal bone mass can be low
Osteoporos Int (2007) 18:495–503 501and not recognised by the edge-detection system. This
artefact can underestimate the bone width in elderly men
and the age-related increase in bone width mainly in the
cross-sectional studies (where the age range is large) but
less so in the longitudinal study (where the follow-up
period is shorter). The projected area of femoral neck may
be overestimated because of calcifications in fibrous tissue.
The measured radius site is established by the device.
According to the individual anatomy, this site may be more
distal (larger and more trabecular) or more proximal
(narrower and cortical). Again, this artefact may introduce
a bias mainly in cross-sectional studies.
Calculation of endosteal bone loss is indirect and based
on the assumptions such as uniform bone flattening,
constant subperiosteal bone vBMD and proportional peri-
osteal expansion in all axes. By contrast, the advantage of
this concept is that we do not make any assumption on the
morphological basis underlying the endosteal bone loss
(cortical thinning or trabecular bone loss, proportion of
cortical to trabecular bone, similar or different rates of
trabecular and cortical bone loss, etc.). Finally, our
calculation of endosteal bone loss was carried out for the
predominantly cortical sites and, although globally consis-
tent with the cross-sectional data obtained by hr-pQCT,
may not necessarily apply for the predominantly trabecular
sites.
In conclusion, in a large cohort of elderly men, age-
related apparent bone loss (aBMD) at the hip, distal forearm
and whole body was determined by the net bone loss
(BMC), except for the femoral neck. Apparent and net bone
loss accelerated with age, whereas the periosteal expansion
rate (widening of ROI) remained constant. At the distal
forearm, age-related acceleration of the apparent bone loss
was determined by the higher endosteal bone loss, whereas
the periosteal apposition rate (estimated mass of deposited
bone) remained constant.
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